Nephroblastoma or Wilms tumour is a type of kidney cancer that commonly affects children. It is a rare condition with only about 500 recorded annual cases in the United States. Its symptoms include abdominal swelling, abdominal pain, blood in the urine, and an abdominal mass. Due to various advancements in the diagnosis and treatment of this condition, patients now have a better prognosis with over 90% five-year survival rate.
Nephroblastoma patients from all over the world can seek comprehensive treatment in Southeast Asia. The region is home to many world-class hospitals that are fully equipped with advanced diagnostic technologies; the same ones used in Western countries. The condition is diagnosed using imaging tests such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) scan. The same tests and technology are used to determine the stage of cancer.
The treatment of nephroblastoma is typically consists of surgery and chemotherapy. Southeast Asia has a number of dedicated children’s cancer centres that offer surgical treatment as well as adjuvant therapy for the treatment of this condition. These specialty centres are staffed by highly qualified surgical and medical oncologists; some of them were trained in the United States and United Kingdom and are recognised by international medical organisations such as the American Society of Paediatric Oncology and the European Society for Paediatric Oncology. In treating paediatric patients, these surgeons typically receive assistance from multidisciplinary teams of doctors who are trained to address other circumstances that surround the patient’s condition.
Comprehensive care for nephroblastoma patients in Southeast Asia is very affordable when compared to Western countries. This is because all the procedures – from consultation to adjuvant therapy – are up to 75% cheaper in the region. Medical tourists can still save thousands of dollars even when associated fees, such as accommodation and airfare, are factored in.